Absci

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Absci and other ETFs, options, and stocks.

About ABSI

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs.

CEO

Sean McClain

CEOSean McClain

Employees

157

Employees157

Headquarters

Vancouver, Washington

HeadquartersVancouver, Washington

Founded

2011

Founded2011

Employees

157

Employees157

ABSI Key Statistics

Market cap

376.94M

Market cap376.94M

Price-Earnings ratio

-3.20

Price-Earnings ratio-3.20

Dividend yield

—

Dividend yield—

Average volume

3.45M

Average volume3.45M

High today

$2.99

High today$2.99

Low today

$2.81

Low today$2.81

Open price

$2.91

Open price$2.91

Volume

2.75M

Volume2.75M

52 Week high

$6.33

52 Week high$6.33

52 Week low

$2.01

52 Week low$2.01

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ABSI. This list is generated using Robinhood data, and it’s not a recommendation.

Recursion Pharmaceuticals

Absci

Why Robinhood?

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. Show more

ABSI Key Statistics

Analyst ratings

100%

People also own

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs.